TN2013000515A1 - Notch pathway signaling inhibitor compound - Google Patents

Notch pathway signaling inhibitor compound

Info

Publication number
TN2013000515A1
TN2013000515A1 TNP2013000515A TN2013000515A TN2013000515A1 TN 2013000515 A1 TN2013000515 A1 TN 2013000515A1 TN P2013000515 A TNP2013000515 A TN P2013000515A TN 2013000515 A TN2013000515 A TN 2013000515A TN 2013000515 A1 TN2013000515 A1 TN 2013000515A1
Authority
TN
Tunisia
Prior art keywords
signaling inhibitor
notch pathway
pathway signaling
inhibitor compound
compound
Prior art date
Application number
TNP2013000515A
Other languages
French (fr)
Inventor
Philip Arthur Hipskind
Gregory Alan Stephenson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2012/047100 external-priority patent/WO2013016081A1/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of TN2013000515A1 publication Critical patent/TN2013000515A1/en

Links

Abstract

The present invention provides a compound, or a pharmaceutically acceptable salt or hydrate, and a pharmaceutical composition containing said compound, or a pharmaceutically acceptable salt or hydrate, useful as a Notch pathway signaling inhibitor for the treatment of cancer
TNP2013000515A 2011-11-16 2013-12-12 Notch pathway signaling inhibitor compound TN2013000515A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161560486P 2011-11-16 2011-11-16
PCT/US2012/047100 WO2013016081A1 (en) 2011-07-27 2012-07-18 Notch pathway signaling inhibitor compound

Publications (1)

Publication Number Publication Date
TN2013000515A1 true TN2013000515A1 (en) 2015-03-30

Family

ID=54359619

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000515A TN2013000515A1 (en) 2011-11-16 2013-12-12 Notch pathway signaling inhibitor compound

Country Status (1)

Country Link
TN (1) TN2013000515A1 (en)

Similar Documents

Publication Publication Date Title
JO3148B1 (en) Notch pathway signaling inhibitor compound
SA515360469B1 (en) Heterocyclic compounds for inhibiting glutaminase and their methods of use
MX351892B (en) Combinations of akt inhibitor compounds and abiraterone, and methods of use.
MX368703B (en) A benzoic acid derivative mdm2 inhibitor for the treatment of cancer.
AU2012214029A8 (en) Rorgammat inhibitors
IN2014DN10670A (en)
MD4659B1 (en) Polymorph of SYK inhibitors
MX2011011335A (en) Inhibitors of pi3 kinase and / or mtor.
MX2011009796A (en) Inhibitors of pi3 kinase.
TN2014000016A1 (en) 4 - piperidinyl compounds for use as tankyrase inhibitors
MD4684B1 (en) Imidazopyrazine-based formulations as SYK inhibitors
JO3115B1 (en) Pyridazinone Compounds and Their Use as DAAO Inhibitors
PH12014502492A1 (en) Pyrazole compounds as sglt1 inhibitors
MX362896B (en) Cis-morpholinone and other compounds as mdm2 inhibitors for the treatment of cancer.
MX362879B (en) Novel uses.
JO3145B1 (en) Compounds useful for inhibiting chk1
TN2013000515A1 (en) Notch pathway signaling inhibitor compound
UA110834C2 (en) Compound inhibitor of notch signaling pathway
TN2014000077A1 (en) Pyridazinone compounds and their use as daao inhibitors
JOP20120346B1 (en) Compounds for adhesion treatment and prevention, compound-related pharmaceutical compositions and methods for the prevention and treatment of adhesions
TN2011000507A1 (en) Inhibitors of pi3 kinase and / or mtor